Goosehead Insurance, Inc
Goosehead Insurance, Inc (GSHD) Financial Performance & Income Statement Overview
Analyze Goosehead Insurance, Inc (GSHD) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Goosehead Insurance, Inc (GSHD) Income Statement & Financial Overview
Review Goosehead Insurance, Inc GSHD income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $75.58M | $93.92M | $78.03M | $78.09M |
| Cost of Revenue | $48.33M | $45.04M | $43.22M | $42.55M |
| Gross Profit | $27.25M | $48.88M | $34.82M | $35.54M |
| Gross Profit Ratio | $0.36 | $0.52 | $0.45 | $0.46 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $17.56M | $17.83M | $15.20M | $17.21M |
| Operating Expenses | $20.64M | $69.24M | $18.38M | $20.10M |
| Total Costs & Expenses | $68.97M | $66.07M | $61.60M | $62.69M |
| Interest Income | $189000.00 | $207000.00 | $231000.00 | $244000.00 |
| Interest Expense | $5.82M | $1.81M | $2.06M | $1.98M |
| Depreciation & Amortization | $2.97M | $2.45M | $2.61M | $2.75M |
| EBITDA | $9.28M | $29.30M | $19.05M | $18.03M |
| EBITDA Ratio | $0.12 | $0.31 | $0.24 | $0.23 |
| Operating Income | $6.61M | $27.85M | $16.44M | $15.40M |
| Operating Income Ratio | $0.09 | $0.30 | $0.21 | $0.20 |
| Other Income/Expenses (Net) | -$5.66M | -$3.17M | -$1.52M | -$1.54M |
| Income Before Tax | $959000.00 | $24.68M | $14.92M | $13.86M |
| Income Before Tax Ratio | $0.01 | $0.26 | $0.19 | $0.18 |
| Income Tax Expense | -$1.69M | $859000.00 | $2.31M | $2.98M |
| Net Income | $2.34M | $14.86M | $7.56M | $6.20M |
| Net Income Ratio | $0.03 | $0.16 | $0.10 | $0.08 |
| EPS | $0.09 | $0.88 | $0.46 | $0.25 |
| Diluted EPS | $0.06 | $0.56 | $0.29 | $0.24 |
| Weighted Avg Shares Outstanding | $24.79M | $24.66M | $24.29M | $24.69M |
| Weighted Avg Shares Outstanding (Diluted) | $38.30M | $38.30M | $37.94M | $38.03M |
Over the past four quarters, Goosehead Insurance, Inc demonstrated steady revenue growth, increasing from $78.09M in Q2 2024 to $75.58M in Q1 2025. Operating income reached $6.61M in Q1 2025, maintaining a consistent 9% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $9.28M, reflecting operational efficiency. Net income dropped to $2.34M, with EPS at $0.09. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan